Ataxion Inc

Private Company

Company Profile

Sector: Health Care
Industry: Biotech & Pharma
Sub-Industry: Biotech
Ataxion, Inc. operates as a biopharmaceutical company. The Company develops novel small-molecule therapeutics for rare, debilitating, and underserved neurologic diseases. Ataxion serves the healthcare sector in United States.

Corporate Information

400 Technology Square
10th Floor
Cambridge, MA 02139
United States
Fax: -

Board Members

CEO/Co-Founder Company
David Grayzel Annovation Biopharma Inc
Board Members Company
Steven Holtzman Decibel Therapeutics
Jean-Francois Formela Atlas Venture LP
Claus Braestrup Aniona
Show More

Sponsored Financial Commentaries

More From The Web